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ABSTRACT
Objective: The association between obesity and
disability may differ between high-income and low-
income/middle-income countries but there are no studies
comparing this association between these settings. The
aim of the study was to assess this association in nine
countries using nationally-representative data from the
Collaborative Research on Ageing in Europe (COURAGE)
study and the WHO’s Study on global AGEing and Adult
Health (SAGE).
Design: Population-based cross-sectional study
Setting: The survey was conducted in China, Finland,
Ghana, India, Mexico, Poland, Russia, South Africa and
Spain between 2007 and 2012.
Participants: 42 116 individuals 50 years and older.
The institutionalised and those with limited cognition were
excluded.
Primary outcome measure: Disability was defined as
severe or extreme difficulty in conducting at least one of
six types of basic activities of daily living (ADL).
Results: The mean body mass index (BMI) ranged from
20.4 kg/m2 in India to 30.7 kg/m2 in South Africa.
Compared to normal BMI (18.5–24.9 kg/m2),
BMI≥35 kg/m2 was associated with significantly higher
odds for ADL disability in Finland (OR 4.64), Poland
(OR 2.77), South Africa (OR 2.19) and Spain (OR 2.42).
Interaction analysis showed that obese individuals in
high-income countries were more likely to have ADL
limitations than those in low-income or middle-income
countries.
Conclusions: The higher odds for disability among
obese individuals in high-income countries may imply
longer life lived with disability due to factors such as the
decline in cardiovascular disease mortality. In South
Africa, this may have been due to the exceptionally high
prevalence of class III obesity. These findings underscore
the importance of obesity prevention to reduce the
disability burden among older adults.
INTRODUCTION
The obesity epidemic has affected both devel-
oping and developed countries alike,1 and
the prevalence and incidence are projected
to rise in the future.2 Obese individuals are at
higher risk for chronic conditions such as car-
diovascular disease (CVD), hypertension, dys-
lipidaemia, diabetes and arthritis,3 and these
conditions often underlie disability among
older individuals.4 The increase in obesity
and obesity-related chronic diseases in the
current context of global population ageing is
likely to increase disability among older
adults in the future.5 This is a major chal-
lenge for the healthcare, social and welfare
services worldwide in terms of the healthcare
costs,6 patients’ quality of life and the burden
for the caregivers.5
Strengths and limitations of this study
▪ We studied the association between obesity and
disability in nine high-income, middle-income and
low-income countries using large nationally-repre-
sentative data sets with information obtained by
standardised questionnaires and measured body
mass index. This is the first study to examine this
association in a variety of settings.
▪ Obese individuals in high-income countries were
more likely to have disability than those in low-
income or middle-income countries. This may be
related to factors such as the decline in cardiovas-
cular disease mortality and the resulting longer
life lived with disability in high-income countries.
▪ Self-report of disability may have been subject to
reporting bias and personal perception of disabil-
ity may have varied across settings.
▪ The exclusion of those with limited cognitive
function and the institutionalised may have
resulted in the exclusion of those with severe
activities of daily living (ADL) impairment result-
ing in a potential underestimation of the associ-
ation between obesity and ADL limitations.
▪ Owing to the cross-sectional nature of the study,
causality cannot be inferred.
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In resource-rich settings, better prevention and
medical management of obesity-related chronic condi-
tions might have counteracted some of the ill-effects of
obesity on health. In the USA, with the exception
of diabetes, cardiovascular risk factors such as hyperten-
sion and high cholesterol have decreased among the
obese population probably due to factors such as wider
use of antihypertensive and lipid-lowering medication.7
Furthermore, mortality among obese individuals has
declined,8 and CVD mortality, the major obesity-related
cause of death, has declined remarkably.9 However, this
may not necessarily have translated into less disability
among obese people. A reduction in CVD mortality and/
or case fatality rates due to better medical care may mean
that obese individuals, who in previous decades would
have died at younger ages, may be living longer at the
cost of more disability due to the sequelae of CVD, or
other disabling conditions such as arthritis.10 A study in
the USA among adults aged ≥60 years has shown a signiﬁ-
cant trend for a higher proportion of obese individuals to
be living with disability compared to their normal-weight
counterparts in more recent years when data of the
National Health and Nutrition Examination Survey
(NHANES) in 1988–1994 (time 1) and 1999–2004
(time 2) were compared.11 In this US study, compared to
normal-weight individuals, obese people had a 1.78 times
higher odds for functional impairment at time 1 but this
increased to 2.75 at time 2. The comparable ﬁgures for
impairments in activities of daily living (ADL) were 1.31
and 2.05, respectively. Moreover, another US study
showed that compared to normal weight, mild obesity
(body mass index (BMI) 30.0–34.9 kg/m2) increases life
expectancy with ADL disability by 2.0 and 3.2 years
among males and females, respectively.12
The association between obesity and disability is
largely unknown in most low-income and middle-income
settings. In contrast to developed countries, limitations
in medical resources may imply less prevention and
control of obesity-related conditions, and thus, more dis-
ability, but higher CVD mortality and/or case-fatality
rates13 may mean that they are less likely to live long
with disability. In addition, individuals in many develop-
ing country settings may have had a shorter period of
exposure to obesity as the obesity epidemic generally
occurred later than in developed countries.1 This may
inﬂuence the difference in the association between
obesity and disability as obesity also leads to negative
health outcomes through its cumulative effects.14
To date, there are no multicontinent studies that
compare the association between obesity and disability
among older adults between countries with different
medical resources and at different stages of the demo-
graphic, nutritional and socioeconomic transition.
Understanding the association between obesity and dis-
ability is important to plan future prevention pro-
grammes. This information is particularly important for
developing country settings where rehabilitation services
are limited and where obesity and disability is increasing
in parallel with the rapid demographic changes. We ana-
lysed nationally-representative data on adults aged
≥50 years from nine countries in Asia, Africa, Europe
and Latin America, using the Collaborative Research on
Ageing in Europe (COURAGE) and the WHO Study on
global AGEing and adult health (SAGE) data sets.
METHODS AND PROCEDURES
Data analysis of the COURAGE and SAGE surveys was per-
formed. The details of the two surveys have been pub-
lished elsewhere.15 16 In brief, the two surveys followed the
same protocol to collect information on health status,
quality of life, disability and well-being among adult
populations using standardised questionnaires. Multistage
clustered sampling design was employed to generate
nationally-representative samples. The sample consisted of
non-institutionalised adults ≥18 years of age with oversam-
pling of those aged ≥50 years. The COURAGE survey was
conducted between 2011 and 2012 in Finland, Poland and
Spain, and the SAGE survey was conducted between 2007
and 2010 in China, Ghana, India, Mexico, Russia and
South Africa. The response rate ranged from 51%
(Mexico) to 93% (China). All data were collected through
face-to-face interviews and measurements by trained inter-
viewers. Height and weight were measured with the use of
a stadiometer and a routinely calibrated electronic weight-
ing scale, respectively. Sampling weights were generated to
adjust for the population structure reported by the
National Institute of Statistics and the United Nations
Statistical Division for the COURAGE and SAGE surveys,
respectively. Informed consent was obtained from all
participants.
Variables
BMI was calculated as weight in kilograms divided by
height in metres squared. BMI was categorised as
<18.5 kg/m2 (underweight), 18.5–24.9 kg/m2 (normal
weight), 25.0–29.9 kg/m2 (overweight), 30.0–34.9 kg/m2
(obesity class I), 35.0–39.9 kg/m2 (obesity class II), and
≥40.0 kg/m2 (obesity class III).3 Although disability may
be deﬁned in various ways, we focused on limitation in
ADL as it represents the severest of the disability mea-
sures, and is an indicator of the ability to live independ-
ently.17 ADL disability was assessed by standard basic ADL
questions18–20 which included six questions with the
introductory phrase “overall in the last 30 days, how
much difﬁculty did you have’ followed by: in washing
your whole body?; in getting dressed?; with moving
around inside your home?; with eating (including cutting
up your food)?; with getting up from lying down?; with
getting to and using the toilet? Answer options were
none, mild, moderate, severe, extreme/cannot do. ADL
disability was a dichotomous variable where those who
answered severe or extreme/cannot do to any of the six
questions were considered to have limitations in ADL. We
deﬁned ADL disability using the most extreme categories
to improve speciﬁcity and also to focus on disability that
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is more likely to be clinically relevant. The presence of
ﬁve chronic medical conditions (angina, arthritis, hyper-
tension, diabetes and stroke) was based on self-report on
whether the participant had ever been diagnosed to have
these conditions. The selection of other covariates used
for adjustment were based on past literature and included
sex, age, highest level of education completed (≤primary,
secondary, ≥tertiary), wealth quintiles based on country-
speciﬁc income, marital status ((currently married/coha-
biting) or not married (never married/separated/
divorced/widowed)) and smoking status (never, current
smoker, quit).19
Statistical analysis
The analysis was restricted to adults over age 50 years.
We focused on individuals aged 50 years or older as the
prevalence of chronic diseases and disabilities is high in
this age group.4
Multivariable logistic regression analyses were per-
formed to assess the association between BMI (independ-
ent variable) and limitations in ADL (dependent
variable). Those with BMI<18.5 kg/m2 were excluded
from this part of the analysis as the aim of our study was to
compare normal weight and higher BMI in terms of the
association between BMI and ADL limitations. This
resulted in 0.5% (Finland) to 38.8% (India) of the partici-
pants to be omitted from this part of the analysis. Obesity
class II and III were collapsed due to small numbers of
class III obesity in most countries. The ﬁrst model
adjusted for sex, age, education, marital status, wealth and
smoking. Since the effect of the highest BMI category
(BMI≥35 kg/m2) on disability could have been affected by
the proportion of those with extreme obesity, we also con-
ducted an additional analysis by deleting those with
BMI≥40 kg/m2 to allow for comparability between coun-
tries. Furthermore, in order to assess whether the associ-
ation between BMI and ADL disability differs by income
level of the countries, we created a dichotomised variable
coded 0 for low-income and middle-income countries
(China, Ghana, India, Mexico, Russia and South Africa)
and 1 for high-income countries (Finland, Poland and
Spain) based on the World Bank classiﬁcation (http://
data.worldbank.org/country/). Although Russia is cur-
rently classiﬁed as a high-income country, it was a
middle-income country at the time of the survey. We
included the product term of BMI category and income
level of country in the adjusted model using pooled data
of all countries. We also constructed a model which used a
BMI category which collapsed obesity class I and class II+
for the interaction analysis as the prevalence of class II+
obesity was low and this could have lead to unstable esti-
mates. The last model included the ﬁve chronic medical
conditions (angina, arthritis, hypertension, diabetes and
stroke) in addition to the covariates in the ﬁrst model to
assess the mediating effect of these conditions on the asso-
ciation between BMI and ADL disability. In addition, in
order to assess the effect of having excluded 38.8% of the
sample from India due to the restriction to individuals
with BMI ≥18.5 kg/m2, we conducted sensitivity analyses
by including those who were underweight in the analysis
for India and the overall sample with the interaction term.
We also conducted sensitivity analyses by using a deﬁnition
of ADL disability including the moderate category in the
deﬁnition for the six questions on ADL (ie, not only severe
and extreme but also moderate) to assess whether the
results change when less extreme categorisations are used.
The sample weighting and the complex study design were
taken into account in all analyses to generate nationally
representative estimates. We analysed data with Stata V.12.1
(Stata Corp LP, College Station, Texas, USA). The level of
statistical signiﬁcance was set at p<0.05.
RESULTS
Baseline characteristics of the analytical sample are
demonstrated in table 1.
The median age ranged from 60 to 65 years. In all
countries except Ghana and India, there were more
females than males. The mean BMI ranged from
20.4 kg/m2 in India to 30.7 kg/m2 in South Africa. The
prevalence of obesity (ie, BMI≥30 kg/m2) was lowest in
the Asian countries (India 2.5% and China 5.8%). In
contrast, over 30% were obese in South Africa (46.9%),
Poland (35.3%), Russia (34.5%) and Spain (31.9%). In
South Africa, 11.6% had class III obesity. In all countries,
arthritis and/or hypertension were the most common
chronic conditions. The prevalence of ADL disability
ranged from 1.6% (China) to 16.6% (Poland). The fre-
quency distribution of all ﬁve categories (none, mild,
moderate, severe and extreme) of the six questions on
ADL by BMI categories and countries are shown in
online supplementary appendix table A1.
Figure 1 illustrates the prevalence of ADL limitations by
BMI category. A clear dose-dependent relationship
between BMI and ADL limitations was observed in
Finland, Poland and Spain. The prevalence (95% CI) of
limitations in ADL when using lower cut-offs for Asia were
1.6% (1.2% to 2.2%), 1.4% (1% to 1.9%) and 1.4% (0.8%
to 2.2%) for BMI 18.5–22.9 kg/m2, 23.0–27.4 kg/m2, and
≥27.5 kg/m2, respectively in China. The corresponding
ﬁgures for India were 10.7% (8.7% to 13%), 11.8% (9% to
15.3%) and 10.1% (6.7% to 15%). The association
between BMI and ADL limitations estimated by multivari-
able logistic regression is shown in table 2. With the excep-
tion of China, a trend for higher BMI to have stronger
associations with ADL limitations compared to normal
weight was observed in most countries although this associ-
ation was not signiﬁcant in some. In China, a non-
signiﬁcant trend for a decrease in the odds for ADL dis-
ability with higher BMI was observed.
Obesity class II+ was associated with a signiﬁcant 4.64
(Finland), 2.77 (Poland), 2.42 (Spain) and 2.19 (South
Africa) times higher odds for ADL disability compared
to normal weight. Additional analysis by excluding those
with BMI≥40 kg/m2 resulted in a loss of signiﬁcance for
obesity class II+ only in South Africa (data not shown).
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The overweight and obesity class I categories were also
associated with a signiﬁcant risk for ADL limitation in
Mexico (OR 2.57) and Poland (OR 1.91), respectively.
Female gender in Spain, and lower education in Spain,
Poland and India were associated with higher odds for
ADL limitations. Tendencies for the richer to have
reduced odds for ADL limitations was observed in most
countries with the exception of India which showed a
U-shaped relationship (ie, the rich and the poor were
less likely to have ADL disability). When data from all
countries were pooled, the OR of the risk for ADL dis-
ability of obesity compared to normal weight was signiﬁ-
cantly higher in high-income countries compared to
low-income and middle- income countries (table 3).
The association between BMI and ADL limitations
adjusting for chronic diseases is illustrated in table 4.
Stoke and arthritis were signiﬁcantly associated with
ADL disability in seven and six countries, respectively.
Angina, diabetes and hypertension were associated with
ADL disability in three countries. After the inclusion of
chronic diseases in the model, most ORs were attenu-
ated and the association between class II+ obesity and
ADL limitation observed in Poland and South Africa
became non-signiﬁcant.
The results of the sensitivity analysis when including
the BMI<18.5 kg/m2 category in the analysis are shown
in online supplementary appendix tables A2a, A2b and
A2c. In the analysis of the association of BMI,
demographic and lifestyle factors with limitations of
ADL in India (see online supplementary table A2a), the
association between BMI 30.0–34.9 kg/m2 (obesity
class I) and ADL disability, which was only of borderline
signiﬁcance in the analysis without BMI<18.5 kg/m2,
became signiﬁcant (OR 2.14 (95% CI 1.22 to 3.77)).
Furthermore, the previously observed U-shaped associ-
ation between wealth and ADL limitation in India was
no longer observed. There were no other major differ-
ences in the other analyses (see online supplementary
table A2b and A2c). The results of the analysis which
used a different deﬁnition of ADL disability (ie,
included moderate category) were similar to those of
the original analysis (see online supplementary tables
A3a, A3b and A3c).
DISCUSSION
Our study shows that the association between obesity and
ADL disability may differ by context. A signiﬁcant associ-
ation between obesity class II+ and ADL disability was
observed in Poland, Finland, Spain and South Africa.
Results from pooled data demonstrated that the risk for
ADL disability among those with obesity is higher com-
pared to individuals with normal weight in high-income
compared to low-income and middle-income countries.
The strength of the study is the large sample size and the
use of nationally-representative datasets obtained by
Figure 1 Prevalence of limitations in activities of daily living (ADL) by BMI category and country. S Africa South Africa; BMI,
body mass index; COURAGE, Collaborative Research on Ageing in Europe; SAGE, WHO Study on global AGEing and adult
health. ADL disability was assessed by six standard basic ADL questions on difficulties in the past 30 days with washing whole
body, getting dressed, moving inside home, eating (including cutting food), getting up from lying down, and getting to and using
the toilet. The answer options to these six questions were none, mild, moderate, severe and extreme/cannot do. ADL disability
was a dichotomous variable where those who answered severe or extreme/cannot do to any of the six questions were
considered to have limitations in ADL. Data presented in figure are per cent. Sampling weights were used to calculate the
prevalence. Bar denotes upper end of 95% CI.
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standardised questionnaires and measured BMI across a
variety of settings with different medical resources and in
different stages of the demographic, epidemiological and
nutritional transition. To the best of our knowledge, this
is the ﬁrst multicontinent study to examine the associ-
ation between BMI and disability.
Several limitations deserve mentioning before discuss-
ing the results. BMI was based on measurement but other
variables such as ADL were based on self-report and may
have been subject to reporting bias. Self-report of ADL,
for example, is dependent on the personal perception of
disability, and this may vary across cultures and countries.
Thus, future studies are warranted to assess whether our
results may be replicated using objective measures of
strength or performance. The reason for the low preva-
lence of ADL disability in China is unclear but a recent
study using the SAGE data set which assessed the corres-
pondence between self-reported and measured mobility
difﬁculty found that the degree of correspondence of
China was relatively low compared to other countries,
where those with measured mobility difﬁculty were less
likely to report mobility difﬁculty.21 Thus, reporting bias
may have been a problem but the clear dose-dependent
association between age and ADL disability observed in
China demonstrates the robustness of this variable. Also,
although self-report of diseases have been shown to dem-
onstrate good agreement with medical records in devel-
oped countries,22 in settings with limited access to
medical facilities or screening for diseases, patients may
be less aware of their illness or may only have them
detected when they are more severe. This may mean that
the mediating effect of chronic diseases on the associ-
ation between BMI and ADL disability may not have been
estimated accurately in some settings. Next, information
on BMI was missing from 3.1% (India) to 11.9%
(Mexico) of the participants. We did not attempt to
impute BMI as we had no information about whether
these data were missing at random.23 Those with ADL
limitations were more likely to have missing BMI, and this
was probably because they were unable to stand by a stadi-
ometer or on a balance. The exclusion of those with
limited cognitive function and the institutionalised may
also have resulted in the exclusion of those with severe
ADL impairment resulting in a potential underestimation
of the association between obesity and ADL limitations.
In addition, in our study, high-income countries only con-
sisted of European countries. Thus, our ﬁndings may not
be generalisable to more ethnically and culturally diverse
high-income settings such as the USA. Finally, because
this was a cross-sectional study, causality cannot be
inferred. For example, obesity might have been the result
of disability rather than the preceding factor for disabil-
ity. All these limitations should be taken into account
when interpreting the data.
The signiﬁcantly higher odds for ADL disability
among the overweight and/or obese individuals com-
pared to those with normal weight observed in our study
accords with the results of a recent meta-analysis
including developed country studies and one Latin
American study which reported pooled ORs to be 1.04
(95% CI 1.00 to 1.08), 1.16 (95% CI 1.11 to 1.21) and
1.76 (95% CI 1.28 to 2.41) for overweight, class I and
class II+ obesity respectively for cross-sectional studies,
and which demonstrated a similar slightly stronger dose-
dependent associations for longitudinal studies.18 The
signiﬁcant association observed in South Africa may
have been attributable to the exceptionally high propor-
tion of class III obesity (11.6%) as when we excluded
individuals with class III obesity from the analysis pre-
sented in table 2, the OR for obesity class II compared
to normal weight remained signiﬁcant for the three
high-income countries but the OR for South Africa
became insigniﬁcant. However, additional analysis by div-
iding the obesity class II+ category into class II and III
obesity for South Africa yielded ORs of 1.95 (95% CI
0.85 to 4.46; p=0.114) and 2.45 (95% CI 1.07 to 5.59;
p=0.033) for class II and III obesity respectively, demon-
strating that obesity class III is associated with higher
odds for ADL limitations in this setting. The strong asso-
ciation between obesity class II+ and ADL limitations
observed in the three high-income countries compared
to other countries might be related to factors such as
longer exposure to obesity, and reduction in
CVD-related mortality observed in developed
countries.13
The reason for the particularly weak association
observed in China is unclear but the analysis of the
China Health and Nutrition Survey revealed a signiﬁcant
positive association between obesity and disability among
older adults in 1997 but a non-signiﬁcant or weaker asso-
ciation in 2006, suggesting that people with obesity have
become healthier in more recent years in China.24
These results contradict the results from one US study,
which found a stronger association in more recent
cohorts,11 and this highlights the potential complex
interplay of factors that may act to weaken (eg, better
primary prevention of obesity-related chronic condi-
tions) or strengthen (eg, reduction in CVD mortality
and longer years lived with disability) the association
between obesity and disability. These factors may com-
pensate in different ways depending on the level of pre-
vention efforts and availability of medical resources of a
setting. We also speculated that the results for China
may have been inﬂuenced by the fact that conventional
BMI categories as the one used in this study may not be
a good predictor for future CVD events particularly in
Asia,25 but the use of lower cut-off points such as BMI
18.5–22.9, 23.0–27.4, ≥27.5 kg/m2 did not alter the asso-
ciation between BMI and disability.
The attenuation of the association between obesity
and disability after the inclusion of chronic conditions
in the model suggest that this association is mediated by
chronic conditions to a certain extent but the fact that
some countries still showed a signiﬁcant association after
adjustment may indicate that obesity is a risk factor for
disability independent of chronic conditions.
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In conclusion, obesity class II+ was associated with
higher risks for disability especially in high-income coun-
tries. This may be related to factors such as the decline
in CVD mortality and the resulting longer life lived with
disability in this setting. Our results suggest that primary
prevention of obesity may have an important role to
prevent disability among older adults especially in coun-
tries where the CVD mortality risk has declined.
However, conﬁrmation of our results are necessary using
data from more culturally and ethnically diverse high-
income settings. In addition, studies using better predic-
tors of CVD risk such as percent body fat rather than
BMI may be necessary especially in Asian countries. An
understanding of the contribution of factors such as
longer exposure to obesity or decrease of CVD mortality
on disability is also necessary. If the paradoxical conse-
quence of lower CVD mortality is indeed more disability,
measures to extend disability-free years would be a prior-
ity. If this paradox is more pronounced in developed
country settings due to better availability of medical
care, developing countries may have to envision this pos-
sible future adversity as a consequence of socioeconomic
development.
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